Holen Sie sich die Stockscreener-App
2.83
5.99%
0.16
Handel nachbörslich:
2.85
0.02
+0.71%
Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten
ETFs Investing in Cabaletta Bio, Inc. Stocks - TradingView
CABA Stock On Track For Best Day In 6 Months After Positive Early Results From Cell Therapy Trial - Stocktwits
Cabaletta Bio : CABA - 24/7 Wall St.
symbol__ Stock Quote Price and Forecast - CNN
Price to earnings forward of Cabaletta Bio, Inc. – NASDAQ:CABA - TradingView
Cabaletta Bio Inc (CABA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cabaletta Bio (CABA) Rallies 2.82% as Biotech Sector Sentiment ImprovesDip Buy Trade - dars.gov.et
Enterprise value to EBIT forward of Cabaletta Bio, Inc. – NASDAQ:CABA - TradingView
Cabaletta Bio Inc (CABA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cabaletta Bio Inc. (CABA) Q1 2026 Earnings: Narrower-than-Feared Loss Drives Positive Investor SentimentManagement Guidance Update - dars.gov.et
CABA Stock Draws Scrutiny As Ownership Filings Shift - timothysykes.com
Cabaletta Bio Inc (CABA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cabaletta Bio Inc (CABA) Institutional Confidence - TradingKey
Cabaletta Bio Inc (CABA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cabaletta Bio Inc (CABA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Certain Common Stock of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 4-JUL-2026. - marketscreener.com
Certain Stock Options of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 4-JUL-2026. - marketscreener.com
Cabaletta Bio (CABA) Stock Forecast & Analyst Ratings - Moomoo
Cabaletta Bio(CABA) Stock Options Chain | Quotes & News - Moomoo
Cabaletta Bio, Inc.(NasdaqGS:CABA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2500 Growth Benchmark - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2000 Index - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2000 Value Benchmark - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2000 Growth Benchmark - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 3000E Growth Benchmark - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 3000E Index - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 3000E Value Benchmark - marketscreener.com
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2500 Index - marketscreener.com
Cabaletta Bio: The Market Sold The EULAR News, I'm Buying (NASDAQ:CABA) - Seeking Alpha
Cabaletta Bio, Inc. Actuals & Estimates (NASDAQ:CABA) - TradingView
CABA Forecast — Price Target — Prediction for 2027 - TradingView
CABACabaletta Bio Inc Volatility & Greeks - Finviz
Cabaletta Bio Hits Reset on RESET-MS Trial, Narrowing Near-Term Upside in Multiple Sclerosis - TipRanks
Cabaletta Bio (CABA) upgraded to buy: Here's why - MSN
Cabaletta Bio (CABA) Edges Higher Amid Sector Volatility: Support and Resistance Levels in FocusATR Stop - dars.gov.et
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Cabaletta Bio Inc (CABA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cabaletta Bio Inc (CABA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cabaletta Bio Inc (CABA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup - Insider Monkey
CABA Technical Analysis & Stock Price Forecast - Intellectia AI
5 Small Cap Stocks with Potential to Rise 1000 Percent - Insider Monkey
Cabaletta Bio Shareholders Approve Share Increase and Directors - The Globe and Mail
Cabaletta Bio (CABA) Proxy filing Summary - Quartr
Cabaletta Bio (NASDAQ: CABA) doubles authorized common shares - Stock Titan
[Form 4] Cabaletta Bio, Inc. Insider Trading Activity - Stock Titan
Director at Cabaletta Bio (CABA) receives grant of 22,000 stock options - Stock Titan
Cabaletta Bio (CABA) director receives stock options for 22,000 shares at $3.22 - Stock Titan
Cabaletta Bio | 4: Statement of changes in beneficial ownership of securities-Director Bollard Catherine - Moomoo
Cabaletta Bio (CABA) director Catherine Bollard receives 22,000 stock options at $3.22 - Stock Titan
0.80%
2.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):